4.7 Article

Distinct Molecular Signatures of Clinical Clusters in People With Type 2 Diabetes: An IMI-RHAPSODY Study

Journal

DIABETES
Volume 70, Issue 11, Pages 2683-2693

Publisher

AMER DIABETES ASSOC
DOI: 10.2337/db20-1281

Keywords

-

Funding

  1. Innovative Medicines Initiative 2 Joint Undertaking [115881]
  2. European Union
  3. EFPIA
  4. Swiss State Secretariat for Education, Research and Innovation (SERI) [16.0097-2]
  5. Wellcome Trust [WT098424AIA, 212625/Z/18/Z, 102820/Z/13/Z]
  6. MRC [MR/R022259/1, MR/J0003042/1, MR/L020149/1]
  7. Diabetes UK [BDA/11/0004210, BDA/15/0005275, BDA 16/0005485]
  8. Foundation for the National Institutes of Health through the Accelerating Medicines Partnership [HART17AMP]
  9. Medical Research Council [MR/L020149/1] Funding Source: researchfish

Ask authors/readers for more resources

This study investigates the molecular signatures of different clusters of individuals with type 2 diabetes, revealing distinct underlying mechanisms and providing novel biological insights into pancreatic islets, liver, and adipose tissue metabolism. The insulin-resistant cluster showed the most distinct molecular signature, while the obese cluster exhibited higher levels of cytokines. Notably, the mild diabetes cluster with high HDL showed the most beneficial molecular profile.
Type 2 diabetes is a multifactorial disease with multiple underlying aetiologies. To address this heterogeneity, investigators of a previous study clustered people with diabetes according to five diabetes subtypes. The aim of the current study is to investigate the etiology of these clusters by comparing their molecular signatures. In three independent cohorts, in total 15,940 individuals were clustered based on five clinical characteristics. In a subset, genetic (N = 12,828), metabolomic (N = 2,945), lipidomic (N = 2,593), and proteomic (N = 1,170) data were obtained in plasma. For each data type, each cluster was compared with the other four clusters as the reference. The insulin-resistant cluster showed the most distinct molecular signature, with higher branched-chain amino acid, diacylglycerol, and triacylglycerol levels and aberrant protein levels in plasma were enriched for proteins in the intracellular PI3K/Akt pathway. The obese cluster showed higher levels of cytokines. The mild diabetes cluster with high HDL showed the most beneficial molecular profile with effects opposite of those seen in the insulin-resistant cluster. This study shows that clustering people with type 2 diabetes can identify underlying molecular mechanisms related to pancreatic islets, liver, and adipose tissue metabolism. This provides novel biological insights into the diverse aetiological processes that would not be evident when type 2 diabetes is viewed as a homogeneous disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available